CellaVision, a producer of digital morphology products for the routine analysis of blood and other body fluids, has entered into an agreement with Beckman Coulter. The agreement gives Beckman Coulter the right to sell CellaVision products in the US. The move is viewed as CellaVision's continuing efforts to strengthen its presence in the US market
By adding CellaVision’s systems and software to their product offering, Beckman Coulter can enhance their hematology automation solution with automatic image analysis of cells and cell changes.
Under this agreement, effective from January 1st 2010, Beckman Coulter will also sell CellaVision’s products in Asia Pacific and parts of Asia, including India and China. CellaVision recognizes these areas as future growth markets.
The company claims that since 2008, products have been sold in the US by the company’s own sales organization in parallel with the distributor, Sysmex America. The company has identified over 2000 potential laboratory customers in North America.
Yvonne Mrtensson, CEO of CellaVision, said: “We are adding a distributor in order to reach a wider segment of the US market and increase awareness about our products. By working with distributors in the US together with our own sales organizations in North America we are accelerating market penetration and increasing our chances for a successful strategic expansion into the North American market. A considerable and growing amount of interest is being shown for our products in both US and Canada.”